Atopic dermatitis

Older adults with atopic eczema are more prone to dementia. Chronic inflammation has emerged as a key predictor and mechanism in the initiation and progression of neuropathologic alterations reported in dementia patients. Atopic eczema, also…

In adolescents and adults with AD, ruxolitinib cream showed a rapid reduction in itch within about 12 hours of the first application. Atopic dermatitis (AD) significantly impacts patient quality of life (QoL) and imposes a…

Atopic dermatitis affects the mental health of adolescents, which in turn affects their psychological well-being. Atopic dermatitis (AD) is an inflammatory, chronic, relapsing skin condition characterized by eczematous lesions and itching, negatively impacting quality of…

Abrocitinib, an oral Janus kinase (JAK) 1 inhibitor, provides an efficacious alternative for adults nonresponsive to other systemic therapies. Atopic Dermatitis (AD) affects 1% to 3% of adults and 15% to 20% of children globally.…

Food allergy is common in moderate-to-severe and early-onset atopic dermatitis. Accurate detection of food allergies is essential for increasing treatment efficacy and preventing unnecessary diets. Atopic dermatitis (AD) is a chronic, recurring, inflammatory skin condition…

Patients with immunodeficiencies and antibody deficiencies typically have atopic symptoms, which should be addressed to avoid worsening of the condition. Primary immunodeficiency diseases (PIDs) are a heterogeneous set of more than 300 inherited immunity abnormalities…